SAVIENT PHARMACEUTICALS INC
SVNT
SVNT was delisted on the 16th of October, 2013.
1 hedge funds and large institutions have $0 invested in SAVIENT PHARMACEUTICALS INC in 2020 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less capital invested
Capital invested by funds: $1K → $0 (-$1K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QAM
QCI Asset Management
Pittsford,
New York
|
-$1K |
SVNT Hedge Fund Activity: Q2 2020 in Review
1 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in SAVIENT PHARMACEUTICALS INC (SVNT) for Q2 2020, worth a combined $0 — down 100% from $1K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of SVNT and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was QCI Asset Management, exiting entirely with an estimated $1K sold.
- 1 institutional investor held SAVIENT PHARMACEUTICALS INC (SVNT) as of Q2 2020, down from 2 in Q1 2020.
- Funds reported $0 of SAVIENT PHARMACEUTICALS INC stock for Q2 2020, down 100% quarter-over-quarter.
- 0 funds opened new SAVIENT PHARMACEUTICALS INC positions in Q2 2020 and 1 closed out, a net change of -1 holder.
- The largest SAVIENT PHARMACEUTICALS INC seller in Q2 2020 was QCI Asset Management, an estimated $1K sold.
Based on aggregated 13F filings for Q2 2020.